Board Meeting
The next board meeting for Ceribell Inc. is on 30 Apr 2025 for the purpose of CeriBell Inc Annual General Meeting for 2025
See details
Ceribell Inc. Key Metrics
Select
All financials are in USD Million and price data in USD
VIEW MORE
Not Eligible
Expensive Valuation
Technically Bearish
Check Before You Buy
VIEW FULL CHECKLISTHigh rank
7Positive7Negative
50.0% Pass in checklist
Check P/E Buy Sell Zone
Not enough data available
Ceribell Inc. Stock Price Analysis
Day Price Range | 14.8 (LTP) 14.315.1 LowHigh |
Week Price Range | 14.8 (LTP) 1415.9 LowHigh |
Month Price Range | 14.8 (LTP) 1021.2 LowHigh |
Ceribell Inc. Live Price Chart
Switch to TradingView
Fetching data ...
Revenue forecast
Hit
Ceribell Inc.'s Revenue was higher than average estimate 1 time in past 1 year
EPS forecast
Current EPS
Avg. Estimate
Hit
EPS is expected to grow by 50.1% in FY25
Consensus Recommendation
5 ANALYST Recommendations
STRONG BUY
The consensus recommendation from 5 analysts for Ceribell Inc. is STRONG BUY
Forecaster is a Premium Feature
You need to upgrade your subscription plan to access this feature
See what you get Ceribell Inc. Stock Analysis
Ceribell Inc. stock analysis with key metrics, changes, and trends.
Ceribell Inc. Metric | VALUE | CHANGE % | TREND | ANALYSIS | |
---|---|---|---|---|---|
Annual Revenue | $65.44 M | 44.71% | positive |
| |
Annual Net Profit | $40.46 M | 37.3% | negative |
| |
Stock Price | $14.84 | -1.07% | positive |
| |
Quarterly Revenue | $18.53 M | 41.15% | positive |
| |
Quarterly Net profit | $12.58 M | 51.99% | negative |
| |
Debt to Equity Ratio | 0.11 | - | positive |
| |
Return on Equity(ROE) | -102.53 % | -102.53% | negative |
| |
Mutual Fund Holding | 28.02 % | 0.87% | positive |
| |
Interest Coverage Ratio | -19.31 | - | negative |
| |
Institutional Holding | 64.38 % | 0.01% | positive |
|
Loading data..
Ceribell Inc. - Company Profile
What does Ceribell Inc. do?
CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.
Ceribell Inc. Management structure
All Gross Remunerations are in USD
Ceribell Inc. Board of directors
All Gross Remunerations are in USD